Clincosm LogoSign in Get a demo

Ovarian Endometrioid Adenocarcinoma

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma

Active, not recruiting
Has Results
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +29 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +572 more
Jan 28, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +25 more
  • Goodyear, Arizona
  • +111 more
Jun 1, 2022

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

Active, not recruiting
  • Ovarian Cancer
  • +9 more
  • Berlin, Germany
  • +14 more
Mar 10, 2022

SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma Trial in Scottsdale (SP-2577, Pembrolizumab)

Withdrawn
  • SCCOHT
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 11, 2022

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Active, not recruiting
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Clinical Observation
  • +4 more
  • Birmingham, Alabama
  • +314 more
Sep 28, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +502 more
Apr 13, 2021

Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

Completed
Has Results
  • Ovarian Endometrioid Adenocarcinoma
  • +8 more
  • Jacksonville, Florida
  • +1 more
Sep 28, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +34 more
  • Gilbert, Arizona
  • +6 more
Aug 27, 2019

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Bevacizumab
  • +5 more
  • Anniston, Alabama
  • +631 more
Jul 19, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma Trial in United States (carboplatin, paclitaxel, docetaxel)

Completed
  • Brenner Tumor
  • +12 more
  • Orange, California
  • +15 more
Jul 19, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,

Completed
  • Brenner Tumor
  • +11 more
  • adjuvant therapy
  • +3 more
  • Orange, California
  • +18 more
Jul 19, 2019